Check hepatitis B markers and vaccination records to decide whether catch-up vaccination is needed
In the Qidong study, vaccination against hepatitis B at birth was associated with an 84% lower risk of later liver cancer. Adults cannot assume the same reduction or get three more doses solely because antibody levels are low. Immunocompetent people who completed the course and previously developed protective antibodies usually do not need a booster. If your vaccination history is unclear, take your results to a vaccination clinic for assessment.
Testing costs a few dozen yuan. For adults who need vaccin…
That study in Qidong used group randomization rather than individual randomization and followed participants f…
Testing costs a few dozen yuan. For adults who need vaccination, 3 hepatitis B doses cost about 100–300 yuan in total; check the local clinic’s charges. The usual schedule is at months 0, 1 and 6.
That study in Qidong used group randomization rather than individual randomization and followed participants for 30 years. For newborns vaccinated with the Hepatitis B vaccine, primary liver cancer decreased by 84%. The confidence interval is 95% CI 23% to 97%. The Hepatitis B surface antigen (HBsAg) positivity rate decreased by 72% (95% CI 68% to 75%); this positivity rate refers to the proportion of people found to be carrying the virus. In the control group, 67.8% of people received catch-up vaccination between the ages of 10 and 14. The efficacy of catch-up vaccination for HBsAg positivity in early adulthood was only 21% (95% CI 10% to 30%), which is much weaker than the vaccine administered at birth. In the entire population of China, the HBsAg positivity proportion decreased by 52% from 1992 to 2014, and decreased by 97% for those aged 5 or younger. These figures cannot be applied directly to adult catch-up vaccination. Immunocompetent people who completed the course and developed protective antibodies retain immune memory after antibody levels fall and usually do not need a booster. Immune memory means the body can rapidly mobilize its defenses when it encounters the virus again. Catch-up decisions should consider vaccination records, surface antigen, surface antibody and core antibody results together. If the history is unclear, seek assessment at a vaccination clinic.
Qu C 等 (2014). Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study. PLoS Medicine:「The estimated efficacy of catch-up vaccination on HBsAg seroprevalence in early adulthood was 21% (95% CI 10%-30%), substantially weaker than that of the neonatal vaccination (72%, 95% CI 68%-75%).」https://doi.org/10.1371/journal.pmed.1001774 ; Cui F 等 (2017). Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerging Infectious Diseases. https://doi.org/10.3201/eid2305.161477;中国疾控中心. 乙型肝炎(疫苗免疫预防、常见问答第 4 问). https://www.chinacdc.cn/jkyj/mygh02/ymkyfjb/yxgy/;CDC. Pink Book, Chapter 10: Hepatitis B(Immunogenicity and Vaccine Efficacy、Serologic Testing of Vaccine Recipients). https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-10-hepatitis-b.html;CDC (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023(表 1、Persons Who Are Fully Vaccinated Against HBV Infection). https://www.cdc.gov/mmwr/volumes/72/rr/rr7201a1.htm
Open source linkAdults who have never been vaccinated, have not completed the course or do not know their history should take vaccination records and test results to a vaccination clinic. If the doctor confirms they remain susceptible, receive the scheduled course or complete the missing doses. One negative antibody test years later does not prove the original vaccination failed. Most people who complete the course do not need repeated antibody tests to decide on boosters. If testing at the specified time after a complete course finds no protective antibodies, a doctor should arrange further vaccination and repeat testing. People on dialysis, with impaired immunity or with occupational blood exposure also need individual assessment. A positive core antibody may indicate previous infection; it does not automatically mean the person has never been infected and needs catch-up vaccination. Vaccines cannot treat an existing infection. If surface antigen HBsAg is positive, seek a liver specialist’s assessment; see section 16, item 11, on liver ultrasound every six months for HBsAg-positive people.